Mediastinal Large B-cell Lymphoma

7 clinical trials · Condition

Record	Firm	Date
Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia (NCT04806035)	TG Therapeutics, Inc.	2021-04-28
Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT02623920)	University of Arizona	2015-12-16
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) (NCT02576990)	Merck Sharp & Dohme LLC	2015-12-02
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies (NCT02362035)	Acerta Pharma BV	2015-02-20

Every clearance here is in the API, with alerts when new ones post.